Literature DB >> 18753941

Adenoma-infiltrating lymphocytes (AILs) are a potential marker of hereditary nonpolyposis colorectal cancer.

Alexandros D Polydorides1, Bhramar Mukherjee, Stephen B Gruber, Barbara J McKenna, Henry D Appelman, Joel K Greenson.   

Abstract

Patients with hereditary nonpolyposis colorectal cancer syndrome (HNPCC) develop microsatellite-unstable colorectal cancers that tend to be more proximally located and are histologically more likely to show high numbers of tumor-infiltrating lymphocytes, a lack of dirty necrosis, mucinous or poor differentiation, and a Crohn-like host immune response, when compared with microsatellite-stable cancers. However, histologic features that are characteristic of and can perhaps distinguish colorectal adenomas in HNPCC patients from those occurring in the general population have not been previously reported. We compared 16 adenomas endoscopically removed from patients with genetically proven HNPCC to 32 control adenomas, group-matched for patient age and sex, along with endoscopic size, shape, anatomic location, and presence of high-grade dysplasia. Adenomas from HNPCC patients were more likely to contain high numbers of adenoma-infiltrating lymphocytes (AILs) with 12 of 16 (75%) adenomas having >or=5 AILs per high-power field (HPF) as opposed to 4 of 32 (12%) adenomas in the control group (P=0.00003). HNPCC adenomas were also less likely to contain increased numbers of apoptotic bodies: 7 of 16 (44%) contained >or=5 apoptoses per HPF, compared with 27 of 36 (84%) control adenomas (P=0.006). The presence of necrosis or serrated architecture, percent villous component, and numbers of mitotic figures per HPF did not differ significantly between the 2 groups. Therefore, increased numbers of AILs and decreased numbers of apoptoses in colorectal adenomas are simple and inexpensive markers that raise the possibility of HNPCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753941      PMCID: PMC3500084          DOI: 10.1097/PAS.0b013e31816ffa80

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  35 in total

1.  High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.

Authors:  R Dolcetti; A Viel; C Doglioni; A Russo; M Guidoboni; E Capozzi; N Vecchiato; E Macrì; M Fornasarig; M Boiocchi
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Surveillance colonoscopy in individuals at risk for hereditary nonpolyposis colorectal cancer: an evidence-based review.

Authors:  Paul M Johnson; Steven Gallinger; Robin S McLeod
Journal:  Dis Colon Rectum       Date:  2006-01       Impact factor: 4.585

3.  Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer.

Authors:  G Lindgren; A Liljegren; E Jaramillo; C Rubio; A Lindblom
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

4.  Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines.

Authors:  Fernando S Velayos; Brian A Allen; Peggy G Conrad; James Gum; Sanjay Kakar; Daniel C Chung; Brindusa Truta; Marvin H Sleisenger; Young S Kim; Jonathan P Terdiman
Journal:  Am J Gastroenterol       Date:  2005-05       Impact factor: 10.864

5.  Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection: correlation with mismatch repair protein expression provides new insights in early steps of tumorigenesis.

Authors:  Giuseppe Giuffrè; Annegret Müller; Thomas Brodegger; Tina Bocker-Edmonston; Johannes Gebert; Matthias Kloor; Wolfgang Dietmaier; Frank Kullmann; Reinhard Büttner; Giovanni Tuccari; Josef Rüschoff
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

6.  Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation.

Authors:  F E M Rijcken; H Hollema; J H Kleibeuker
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

7.  Variables associated with the risk of colorectal adenomas in asymptomatic patients with a family history of colorectal cancer.

Authors:  P Gaglia; W S Atkin; S Whitelaw; I C Talbot; C B Williams; J M Northover; S V Hodgson
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

8.  Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer.

Authors:  Jinru Shia; Nathan A Ellis; Philip B Paty; Garrett M Nash; Jing Qin; Kenneth Offit; Xin-Min Zhang; Arnold J Markowitz; Khedoudja Nafa; Jose G Guillem; W Douglas Wong; William L Gerald; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2003-11       Impact factor: 6.394

9.  The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC.

Authors:  Andrea E De Jong; Hans Morreau; Marjo Van Puijenbroek; Paul H c Eilers; Juul Wijnen; Fokko M Nagengast; Gerrit Griffioen; Annemieke Cats; Fred H Menko; Jan H Kleibeuker; Hans F A Vasen
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

10.  Flat adenoma as a precursor of colorectal carcinoma in hereditary nonpolyposis colorectal carcinoma.

Authors:  T Watanabe; T Muto; T Sawada; M Miyaki
Journal:  Cancer       Date:  1996-02-15       Impact factor: 6.860

View more
  7 in total

1.  Can a gastrointestinal pathologist identify microsatellite instability in colorectal cancer with reproducibility and a high degree of specificity?

Authors:  Eli Brazowski; Paul Rozen; Sara Pel; Ziona Samuel; Irit Solar; Guy Rosner
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

2.  Immunohistochemical testing of conventional adenomas for loss of expression of mismatch repair proteins in Lynch syndrome mutation carriers: a case series from the Australasian site of the colon cancer family registry.

Authors:  Michael D Walsh; Daniel D Buchanan; Sally-Ann Pearson; Mark Clendenning; Mark A Jenkins; Aung Ko Win; Rhiannon J Walters; Kevin J Spring; Belinda Nagler; Erika Pavluk; Sven T Arnold; Jack Goldblatt; Jill George; Graeme K Suthers; Kerry Phillips; John L Hopper; Jeremy R Jass; John A Baron; Dennis J Ahnen; Stephen N Thibodeau; Noralane Lindor; Susan Parry; Neal I Walker; Christophe Rosty; Joanne P Young
Journal:  Mod Pathol       Date:  2012-02-10       Impact factor: 7.842

Review 3.  Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients.

Authors:  Kristen M Drescher; Poonam Sharma; Henry T Lynch
Journal:  Clin Dev Immunol       Date:  2010-06-10

4.  Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case.

Authors:  Jinru Shia; Zsofia K Stadler; Martin R Weiser; Efsevia Vakiani; Robin Mendelsohn; Arnold J Markowitz; Moshe Shike; C Richard Boland; David S Klimstra
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

5.  Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma.

Authors:  Isabella Lupi; Luca Manetti; Patrizio Caturegli; Michele Menicagli; Mirco Cosottini; Aldo Iannelli; Giovanni Acerbi; Generoso Bevilacqua; Fausto Bogazzi; Enio Martino
Journal:  J Clin Endocrinol Metab       Date:  2009-10-29       Impact factor: 5.958

6.  Specimens from biopsies of colorectal polyps often harbor additional diagnoses.

Authors:  Shefali Chopra; Mark Li-Cheng Wu
Journal:  Patholog Res Int       Date:  2013-12-24

7.  Eosinophils in Colorectal Neoplasms Associated with Expression of CCL11 and CCL24.

Authors:  Hyuck Cho; Sung-Jig Lim; Kyu Yeoun Won; Go Eun Bae; Gou Young Kim; Ji Won Min; Byeong-Joo Noh
Journal:  J Pathol Transl Med       Date:  2015-12-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.